After Plunging -24.47% in 4 Weeks, Here’s Why the Trend Might Reverse for Health Catalyst (HCAT)
ZacksThe heavy selling pressure might have exhausted for Health Catalyst (HCAT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.